Sign in

CIK 0001653087

  • Accelerated filer
  • Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
822933343
Phone
+1 415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-03 Rosenthal Arnon Chief Executive Officer Sale −104,347 $1.12 $117K 2,420,040
2025-09-02 Wong-Sarad Grace Principal Accounting Officer Sale −5,910 $2.50 $15K 103,448
2025-09-02 Berkley Neil Lindsay Principal Financial Officer Sale −15,842 $2.50 $40K 346,570
2025-09-02 Kenkare-Mitra Sara President and Head of R&D Sale −23,638 $2.50 $59K 543,339
2025-09-02 Rosenthal Arnon Chief Executive Officer Sale −51,562 $2.50 $129K 2,350,220
2025-08-26 Hammond Paula Director Sale 10b5-1 −14,000 $2.36 $33K 74,909
2025-06-20 Yaffe Kristine Director Sale 10b5-1 −1,000 $1.44 $1K 95,409
2025-06-02 GRASSO MARC Chief Financial Officer Sale −16,488 $1.34 $22K 296,072
2025-06-02 Kenkare-Mitra Sara President and Head of R&D Sale −23,890 $1.34 $32K 512,252
2025-06-02 Rosenthal Arnon Chief Executive Officer Sale −52,087 $1.34 $70K 2,414,657
2025-03-03 GRASSO MARC Chief Financial Officer Sale −18,091 $1.47 $27K 312,560
2025-03-03 Kenkare-Mitra Sara President and Head of R&D Sale −29,073 $1.47 $43K 536,142
2025-03-03 Rosenthal Arnon Chief Executive Officer Sale −40,330 $1.47 $59K 2,466,744
2025-03-03 Romano Gary Chief Medical Officer Sale −16,306 $1.47 $24K 332,977
2024-12-02 GRASSO MARC Chief Financial Officer Sale −16,489 $2.52 $42K 330,651
2024-12-02 Rosenthal Arnon Chief Executive Officer Sale −52,172 $2.52 $131K 2,507,074
2024-12-02 Kenkare-Mitra Sara President and Head of R&D Sale −26,500 $2.52 $67K 565,215
2024-12-02 Romano Gary Chief Medical Officer Sale −14,892 $2.52 $38K 349,283
2024-09-03 GRASSO MARC Chief Financial Officer Sale −7,297 $4.88 $36K 130,740
2024-09-03 Rosenthal Arnon Chief Executive Officer Sale −26,499 $4.88 $129K 1,948,746

Page 2 of 13 · 249 trades